That muscle preservation translates directly into a higher resting metabolic rate, a larger daily calorie burn, and a significantly reduced likelihood of prolonged stalls
Kokkorakis M, Chakhtoura M, Rhayem C et al (2025) Emerging pharmacotherapies for obesity: a systematic review
John Foundation in support of a center focused on translational engineering and medicine
Storage instructions can vary depending on the specific formulation from the compounding pharmacy

Examples include: peptide therapy (at high doses or long-term use) TB-500 (Thymosin Beta-4) VEGF-mimetic peptides Tesamorelin/peptide therapy (via IGF-1 pathways) Potential risks of prolonged use: Scar tissue overdevelopment Feeding abnormal or cancerous cell growth Disrupting blood flow in sensitive tissues (eyes, kidneys) Thats why we recommend cycles like: TB-500 : 610 weeks on, 4+ weeks off peptide therapy injections : short-term, with oral BPC for maintenance Tesamorelin/peptide therapy : rotated or paused to avoid overexposure Other Peptides That Benefit From Cycling Even non-angiogenic peptides benefit from breaks: Thymosin Alpha-1 : 5-week cycles, 23x per year GHK-Cu : 78 week cycles, followed by rest Semax & Dihexa : pulsed use to maintain brain sensitivity 5-Amino-1MQ : cycled after 23 rounds for metabolic reset Each protocol is tailored to half-life, tissue targets, and sensitivity feedback
During the initial phase, it is normal for the treated area to be red and feel hot